相似文献
1
[Drug monitoring and regulatory aspects of psychotropic drugs in childhood and adolescence].
Z Kinder Jugendpsychiatr Psychother. 2009 Jul;37(4):280-2.
2
["Therapeutic drug monitoring", a strategy for improving drug safety in child and adolescent psychiatry and psychotherapy].
Z Kinder Jugendpsychiatr Psychother. 2005 Jul;33(3):157-8. doi: 10.1024/1422-4917.33.3.157.
3
Practical clinical issues regarding child and adolescent psychopharmacology.
Child Adolesc Psychiatr Clin N Am. 2000 Jan;9(1):245-60.
4
[Off-label use of drugs in psychiatry and neurology].
Fortschr Neurol Psychiatr. 2004 May;72(5):243-4. doi: 10.1055/s-2003-812452.
5
Therapeutic drug monitoring. Principles and practice.
Psychiatr Clin North Am. 1993 Sep;16(3):611-45.
6
[Possibilities of concomitant drug treatment of stuttering in childhood and adolescence].
Z Kinder Jugendpsychiatr. 1995 Sep;23(3):182-94.
7
Drug interactions in psychopharmacology.
Psychiatr Clin North Am. 1993 Sep;16(3):647-71.
8
Regulatory issues in pediatric psychopharmacology.
J Am Acad Child Adolesc Psychiatry. 1996 Oct;35(10):1276-82. doi: 10.1097/00004583-199610000-00014.
9
Comorbidity in psychiatry: its impact on psychopharmacological treatment.
Psychiatr Danub. 2009 Sep;21(3):347-9.
Zotero 插件